Quantitative/qualitative analysis using LC-HRMS: The fundamental step forward for clinical laboratories and clinical practice

Bioanalysis

Volumn 4, Issue 14, 2012, Pages 1709-1711

  Rochat, Bertrand ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

clinical analysis; high resolution; LC MS metabotyping; phenotyping; quantitative qualitative

Indexed keywords

ACCURACY; CLINICAL LABORATORY; CLINICAL PRACTICE; GOLD STANDARD; HIGH THROUGHPUT SEQUENCING; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; PHENOTYPE; PRACTICE GUIDELINE; QUADRUPOLE MASS SPECTROMETRY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; TIME OF FLIGHT MASS SPECTROMETRY; TRIPLE QUADRUPOLE MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; HUMANS; LABORATORIES, HOSPITAL; MASS SPECTROMETRY; METABOLOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84865018531     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.159     Document Type: Review

References (20)

1. Viette V, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL. Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods. Clin. Chem. Lab. Med. 49, 1091-1103 (2011
2. Zhang NR, Yu S, Tiller P, Yeh S, Mahan E, Emary WB. Quantitation of small molecules using high-resolution accurate mass spectrometers - a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom. 23, 1085-1094 (2009
3. Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 25, 979-992 (2011
4. Ramanathan R, Jemal M, Ramagiri S et al. It is time for a paradigm shift in drug discovery bioanalysis: From SRM to HRMS. J. Mass Spectrom. 46, 595-601 (2011
5. Henry H, Sobhi HR, Scheibner O, Bromirski M, Nimkar SB, Rochat B. Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs. Rapid Commun. Mass Spectrom. 26, 499-509 (2012
6. Dillen L, Cools W, Vereyken L et al. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis 4, 565-579 (2012
7. Kellmann M, Muenster H, Zomer P, Mol H. Full scan MS in comprehensive qualitative and quantitative residue analysis in food and feed matrices: how much resolving power is required? J. Am. Soc. Mass Spectrom. 20, 1464-1476, (2009
8. Williamson LN, Zhang G, Terry Jr AV, Bartlett MG. Comparison of time-of-flight mass spectrometry to triple quadrupole tandom mass spectrometry for quantitative bioanalysis: Application to antipsychotics. J. Liq. Chromatogr. Relat. Technol. 31, 2737-2751 (2008
9. Wang J, Leung D, Chow W. Applications of LC/ESI-MS/MS and UHPLC QqTOF-MS for the determination of 148 pesticides in berries. J. Agric. Food Chem. 58, 5904-5925 (2008
10. Kaufmann A. The current role of high-resolution mass spectrometry in food analysis. Anal. Bioanal. Chem. 403, 1233-1249 (2012
11. Ramanathan R, Korfmacher W. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena. Bioanalysis 4, 467-469 (2012
12. Josephs JL. HRMS: Current usage, future directions and the promise of integration with unified data streams suited to post-acquisition mining. Bioanalysis 4, 471-476 (2012
13. Johnson CH, Patterson AD, Idle JR, Gonzalez FJ. Xenobiotic metabolomics: major impact on the metabolome. Annu. Rev. Pharmacol. Toxicol. 52, 37-56 (2012
14. Psychogios N, Hau DD, Peng J et al. The human serum metabolome. PLoS One 16, 6 (2011
15. Dunn WB, Broadhurst D, Begley P et al.; Human Serum Metabolome (HUSERMET) Consortium. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060-1083 (2011
16. Johnson CH, Gonzalez FJ. Challenges and opportunities of metabolomics. J. Cell Physiol. 227, 2975-2981. (2012
17. Patterson AD, Maurhofer O, Beyoglu D et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res. 71, 6590-6600 (2011
18. Wang TJ, Larson MG, Vasan RS et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453 (2011
19. Phapale PB, Kim SD, Lee HW et al. An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus. Clin. Pharmacol. Ther. 87, 426-436 (2010
20. Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 12, 103-111 (2011